tiprankstipranks
BioNTech SE (BNTX)
NASDAQ:BNTX

BioNTech SE (BNTX) Cash flow

4,106 Followers

BioNTech SE Cash Flow

BNTX's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, BNTX's free cash flow was decreased by $-8.58B and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 3.92B$ 5.37B$ 13.58B$ 889.70M$ -13.50M$ -198.54M
Investing Cash Flow
$ -78.40M$ -6.95B$ -35.30M$ -566.10M$ -144.80M$ -77.11M
Financing Cash Flow
$ -781.50M$ -778.60M$ -1.42B$ 94.20M$ 894.70M$ 383.29M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 9.33B$ 11.66B$ 13.82B$ 1.63B$ 1.21B$ 519.15M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--$ 110.50M$ 160.90M$ 753.00M$ 375.35M
Issuance Of Debt
$ 200.00K$ -40.10M$ -59.10M$ -66.70M$ 156.00M$ 11.00M
Repayment Of Debt
$ -10.50M$ -40.40M$ -59.90M$ -66.70M$ -14.30M$ -3.06M
Free Cash Flow
$ 3.84B$ 4.67B$ 13.25B$ 765.60M$ -98.90M$ -269.62M
Domestic Sales
------
Foreign Sales
------
Currency in USD

BioNTech SE Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis